Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Idiopathic Parkinson's Disease by a neurologist, using a specific set of recognised diagnostic guidelines (known as the UK Parkinson's Disease Association Brain Bank criteria)
- People whose Parkinson's disease falls within stages I to III on a standard rating scale called the Hoehn and Yahr scale, which covers mild to moderate stages of the condition
- People who score 21 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
- People who have access to the necessary technology at home to take part in remote, online rehabilitation sessions
- People who are able to walk at least 100 metres
- People who have completed at least primary school level education
Who may not be able to join:
- People who have a neurological condition in addition to Parkinson's disease
- People who have a heart, lung, or joint/muscle problem that affects the way they walk or their ability to balance
- People who are currently receiving Deep Brain Stimulation (DBS) therapy, or who have had DBS surgery at any point in the past (DBS is a treatment that involves a device implanted in the brain)
- People who have vision or hearing difficulties
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Semra Oğuz, PhD, Marmara University
Phone: +905055624837
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in motor impairment; Change in behavioral regulations in exercise; Change in lower extremity power and endurance; Change in walking speed; Change in mobility; Change in body position; Change in quality of life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.